Workflow
东方红医疗创新混合型证券投资基金(QDII)基金份额发售公告

Group 1 - The fund is named "Oriental Red Medical Innovation Mixed Securities Investment Fund (QDII)" and is a mixed-type open-ended fund approved by the China Securities Regulatory Commission (CSRC) [1][18] - The fund's minimum total subscription amount is set at 200 million units, and the minimum fundraising amount is 200 million RMB, excluding interest [6][17] - The fundraising period is from September 10, 2025, to September 23, 2025, with the possibility of extension not exceeding three months [5][19] Group 2 - The fund offers two classes of shares: Class A and Class C, with different fee structures. Class A charges subscription fees, while Class C does not charge subscription fees but incurs service fees from the fund's assets [5][25] - The minimum subscription amount for each class of shares is set at 10 RMB when processed through the fund manager's direct sales center [11][22] - Investors must use the company's open-end fund account for subscription, and those without an account can open one through direct or agent sales institutions [4][29] Group 3 - The fund primarily invests in publicly listed companies in the medical innovation sector, aiming to achieve returns that exceed the performance benchmark while strictly controlling investment risks [18] - The fund's management is conducted by Shanghai Oriental Securities Asset Management Co., Ltd., with Shanghai Pudong Development Bank as the custodian [3][51] - The fund's net asset value may fluctuate due to market volatility, and investors are encouraged to read the fund's prospectus and related documents for detailed information [9][7]